MedPath

Comparison of the effect of Cysteamine 5% cream with Tranexamic acid Mesotherapy on the severity of epidermal Melasma.

Phase 3
Completed
Conditions
Epidermal Melasma.
Other epidermal thickening
Registration Number
IRCT20181006041252N2
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
54
Inclusion Criteria

Age between 20 and 50 years
Patients who have been at least 6 months old since their illness
Patients who have not received any medication for at least 2 months

Exclusion Criteria

History of Endocrine diseases, pregnancy and breast feeding
Any Corticosteroids treatment 3 months before study
Use of oral contraceptive pills before study
Other skin diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.